4//SEC Filing
Voigt Michel James 4
Accession 0001415889-25-006307
CIK 0000856982other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:22 PM ET
Size
22.7 KB
Accession
0001415889-25-006307
Insider Transaction Report
Form 4
Voigt Michel James
CHIEF HUMAN RESOURCES OFFICER
Transactions
- Tax Payment
Common Stock, No Par Value
2025-02-27$98.50/sh−4,530$446,205→ 16,911 total - Exercise/Conversion
Common Stock, No Par Value
2025-02-28$65.03/sh+4,048$263,241→ 33,708 total - Exercise/Conversion
Common Stock, No Par Value
2025-02-28$70.58/sh+2,500$176,450→ 36,208 total - Sale
Common Stock, No Par Value
2025-02-28$99.68/sh−13,809$1,376,481→ 22,399 total - Exercise/Conversion
Non-qualified stock options (right to buy)
2025-02-28−7,261→ 2,420 totalExercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (9,681 underlying) - Award
Common Stock, No Par Value
2025-02-28+5,488→ 22,399 total - Exercise/Conversion
Non-qualified stock options (right to buy)
2025-02-28−2,500→ 11,076 totalExercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (13,576 underlying) - Award
Common Stock, No Par Value
2025-02-27+11,533→ 21,441 total - Exercise/Conversion
Common Stock, No Par Value
2025-02-28$56.25/sh+7,261$408,431→ 29,660 total - Exercise/Conversion
Non-qualified stock options (right to buy)
2025-02-28−4,048→ 4,046 totalExercise: $65.03From: 2023-02-28Exp: 2029-02-28→ Common Stock (8,094 underlying)
Holdings
- 15(indirect: By 401(k))
Common Stock, No Par Value
Footnotes (8)
- [F1]Represents plan holdings as of 02/28/2025.
- [F2]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.28.2022.
- [F3]The Reporting Person surrendered 4,530 shares of common stock to the Issuer for payroll taxes. No shares were sold in the open market.
- [F4]Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
- [F5]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.425 to $100.485, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F6]Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
- [F7]Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
- [F8]Become exercisable in equal annual installments of 25% commencing on 02/28/2024.
Documents
Issuer
MERIT MEDICAL SYSTEMS INC
CIK 0000856982
Entity typeother
Related Parties
1- filerCIK 0001836958
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:22 PM ET
- Size
- 22.7 KB